ArticleEJIFCC2026
Analytical Performance of an Alternative Wavelength in the O-CPC Calcium Assay.
Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The o-cresolphthalein complexone (O-CPC) method is widely used for serum calcium measurement but may exhibit analytical limitations related to background absorbance and bias, particularly at low calcium concentrations. This study evaluated the analytical performance of an alternative wavelength (524 nm) compared with the conventional 572 nm measurement. Methods: Spectral analysis of the calcium-O-CPC complex identified a secondary absorbance feature near 536 nm. Because this wavelength was not available in routine analysers, 524 nm was selected as the nearest operational alternative for analytical evaluation. Performance was assessed using multipoint calibration models, control sera, precision analysis, and comparison with an automated analyzer in 40 samples, including prepared mixtures to extend the analytical range. Agreement between methods was evaluated using regression and Bland-Altman analyses. Results: Reagent blank absorbance was lower at 524 nm compared with 572 nm (0.048 vs 0.122). Linearity was high at both wavelengths (R Conclusions: Measurement at 524 nm demonstrated comparable overall analytical performance to the conventional 572 nm wavelength and was associated with reduced negative bias in the low concentration range. These findings suggest that alternative wavelength selection may represent a practical approach for optimizing analytical performance in routine O-CPC calcium assays.
Indexed as
Identifiers
42730034PMC13563543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.